0001209191-22-004492.txt : 20220121
0001209191-22-004492.hdr.sgml : 20220121
20220121184943
ACCESSION NUMBER: 0001209191-22-004492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220121
DATE AS OF CHANGE: 20220121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guzzo Anthony J.
CENTRAL INDEX KEY: 0001432098
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39094
FILM NUMBER: 22547092
MAIL ADDRESS:
STREET 1: C/O US SHIPPING PARTNERS L.P.
STREET 2: 399 THORNALL STREET
CITY: EDISON
STATE: NJ
ZIP: 08837
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001783183
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824151574
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (877) 742-8466
MAIL ADDRESS:
STREET 1: 100 CAMPUS DRIVE,
STREET 2: SUITE 102
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-19
0
0001783183
Phathom Pharmaceuticals, Inc.
PHAT
0001432098
Guzzo Anthony J.
C/O PHATHOM PHARMACEUTICALS, INC.
100 CAMPUS DRIVE, SUITE 102
FLORHAM PAK
NJ
07932
0
1
0
0
VP, Chief Accounting Officer
Common Stock
2022-01-19
4
A
0
6000
0.00
A
8399
D
Common Stock
463.55
I
by 401(k)
Stock Option (Right to Buy)
15.21
2022-01-19
4
A
0
30000
0.00
A
2032-01-18
Common Stock
30000
30000
D
Represents restricted stock units ("RSUs") granted on January 19, 2022. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of January 19, 2022, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
Includes 2,399 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2021 and January 2022.
The stock option will vest with respect to 25% of the shares of common stock on January 19, 2023, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.
/s/ Larry Miller, Attorney-in-Fact for Anthony J. Guzzo
2022-01-21